Exciting News!
MONCYTE Health is proud to announce its participation in the upcoming American Heart Association (AHA) Scientific Sessions, taking place this week.
Our team will be presenting two sets of groundbreaking clinical data that highlight our continued commitment to advancing cardiovascular research and precision medicine.
1️⃣ MONCYTE Health Presentation:
“Linking variability of leukocyte lipid metabolism to circulating lipids, lipoprotein composition and cardiovascular risk in the Finnish adult population.”
This study provides new insights into how lipid metabolism at the cellular level connects to systemic lipid profiles and cardiovascular risk.
2️⃣ Collaborative Presentation with Baylor College of Medicine:
“c-Rel–Mediated Lipid Accumulation and Inflammatory Activation in Monocytes in Hypertriglyceridemia.”
This collaborative research explores the mechanisms of inflammation and lipid accumulation, shedding light on the molecular pathways contributing to cardiovascular disease.
We are honored to contribute meaningful data that support the global effort to innovate and improve cardiovascular health. If you are attending the AHA Scientific Sessions, we invite you to connect with our team and learn more about how MONCYTE Health is advancing the science of heart health.
